These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12432241)

  • 41. Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1.
    Jacques C; Lamoureux F; Baud'huin M; Rodriguez Calleja L; Quillard T; Amiaud J; Tirode F; Rédini F; Bradner JE; Heymann D; Ory B
    Oncotarget; 2016 Apr; 7(17):24125-40. PubMed ID: 27006472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The EWS/FLI1 oncogenic transcription factor deregulates GLI1.
    Zwerner JP; Joo J; Warner KL; Christensen L; Hu-Lieskovan S; Triche TJ; May WA
    Oncogene; 2008 May; 27(23):3282-91. PubMed ID: 18084326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relation of neurological marker expression and EWS gene fusion types in MIC2/CD99-positive tumors of the Ewing family.
    Amann G; Zoubek A; Salzer-Kuntschik M; Windhager R; Kovar H
    Hum Pathol; 1999 Sep; 30(9):1058-64. PubMed ID: 10492040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma.
    Riggi N; Knoechel B; Gillespie SM; Rheinbay E; Boulay G; Suvà ML; Rossetti NE; Boonseng WE; Oksuz O; Cook EB; Formey A; Patel A; Gymrek M; Thapar V; Deshpande V; Ting DT; Hornicek FJ; Nielsen GP; Stamenkovic I; Aryee MJ; Bernstein BE; Rivera MN
    Cancer Cell; 2014 Nov; 26(5):668-681. PubMed ID: 25453903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absence of detectable EWS/FLI1 expression after therapy-induced neural differentiation in Ewing sarcoma.
    Knezevich SR; Hendson G; Mathers JA; Carpenter B; Lopez-Terrada D; Brown KL; Sorensen PH
    Hum Pathol; 1998 Mar; 29(3):289-94. PubMed ID: 9496833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1.
    Giorgi C; Boro A; Rechfeld F; Lopez-Garcia LA; Gierisch ME; Schäfer BW; Niggli FK
    Oncotarget; 2015 Oct; 6(30):28895-910. PubMed ID: 26336820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adamantinoma-like Ewing's sarcoma: genomic confirmation, phenotypic drift.
    Bridge JA; Fidler ME; Neff JR; Degenhardt J; Wang M; Walker C; Dorfman HD; Baker KS; Seemayer TA
    Am J Surg Pathol; 1999 Feb; 23(2):159-65. PubMed ID: 9989842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EWS/FLI1 suppresses retinoblastoma protein function and senescence in Ewing's sarcoma cells.
    Hu HM; Zielinska-Kwiatkowska A; Munro K; Wilcox J; Wu DY; Yang L; Chansky HA
    J Orthop Res; 2008 Jun; 26(6):886-93. PubMed ID: 18271016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetically defined EWS/FLI1 model system suggests mesenchymal origin of Ewing's family tumors.
    Potikyan G; France KA; Carlson MR; Dong J; Nelson SF; Denny CT
    Lab Invest; 2008 Dec; 88(12):1291-302. PubMed ID: 18838963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Detection of EWS-FLI1 fusion transcript in Ewing's sarcoma/peripheral primitive neuroectodermal tumors by one-step RT-PCR using paraffin-embedded tissues].
    Li F; Chang B; Li XX; Pang LJ; Lu HF; Wang J; Sun MH; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):328-31. PubMed ID: 15363317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas.
    Zhang J; Hu S; Schofield DE; Sorensen PH; Triche TJ
    Cancer Res; 2004 Sep; 64(17):6026-34. PubMed ID: 15342383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single-chain antibodies to the EWS NH(2) terminus structurally discriminate between intact and chimeric EWS in Ewing's sarcoma and interfere with the transcriptional activity of EWS in vivo.
    Aryee DN; Kreppel M; Bachmaier R; Uren A; Muehlbacher K; Wagner S; Breiteneder H; Ban J; Toretsky JA; Kovar H
    Cancer Res; 2006 Oct; 66(20):9862-9. PubMed ID: 17047047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ewing's sarcoma: general insights from a rare model.
    Davis S; Meltzer PS
    Cancer Cell; 2006 May; 9(5):331-2. PubMed ID: 16697953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
    Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T
    Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EWS/ETS fusions activate telomerase in Ewing's tumors.
    Takahashi A; Higashino F; Aoyagi M; Yoshida K; Itoh M; Kyo S; Ohno T; Taira T; Ariga H; Nakajima K; Hatta M; Kobayashi M; Sano H; Kohgo T; Shindoh M
    Cancer Res; 2003 Dec; 63(23):8338-44. PubMed ID: 14678994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene.
    Thompson AD; Braun BS; Arvand A; Stewart SD; May WA; Chen E; Korenberg J; Denny C
    Oncogene; 1996 Dec; 13(12):2649-58. PubMed ID: 9000139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. EWS-FLI1 induces developmental abnormalities and accelerates sarcoma formation in a transgenic mouse model.
    Lin PP; Pandey MK; Jin F; Xiong S; Deavers M; Parant JM; Lozano G
    Cancer Res; 2008 Nov; 68(21):8968-75. PubMed ID: 18974141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
    Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ
    Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EWS-FLI1 fusion transcripts identified in patients with typical neuroblastoma.
    Burchill SA; Wheeldon J; Cullinane C; Lewis IJ
    Eur J Cancer; 1997 Feb; 33(2):239-43. PubMed ID: 9135495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
    Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
    Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.